BacLite Rapid MRSA Clinical Performance
- Conditions
- Methicillin Resistance
- Registration Number
- NCT00541632
- Lead Sponsor
- Solventum US LLC
- Brief Summary
The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
- Subjects 18 years or older
- Subjects willing to document demographic characteristics
- Subjects willing to have their nose swabbed
- Subjects (or legal representative) willing to sign consent and authorization forms
- Subjects who use Vicks Sinex Nasal spray or other nasal sprays
- Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects
- Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares
- Investigator believes that subject is unsuitable for inclusion.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
Denver Health Medical Center
🇺🇸Denver, Colorado, United States
Atlanta Institute for Medical Research, Inc.
🇺🇸Atlanta, Georgia, United States
Evanston Northwestern Healthcare
🇺🇸Evanston, Illinois, United States
University of Iowa
🇺🇸Iowa City, Iowa, United States
University of Maryland
🇺🇸Baltimore, Maryland, United States
Wayne State University
🇺🇸Detroit, Michigan, United States
Washington University
🇺🇸Saint Louis, Missouri, United States
Wake Forest University
🇺🇸Winston-Salem, North Carolina, United States
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States